Detalles de la búsqueda
1.
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.
Am Heart J
; 165(3): 344-53.e1, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23453103
2.
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Circulation
; 119(5): 680-6, 2009 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19171853
3.
Comparison of a Drug-Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3-Year Follow-Up.
J Am Heart Assoc
; 6(6)2017 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600401
4.
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol
; 69(4): 367-377, 2017 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815101
5.
The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent.
Eur Heart J Qual Care Clin Outcomes
; 2(2): 108-116, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474621
Resultados
1 -
5
de 5
1
Próxima >
>>